The Serbian authorities are ready to consider the possibility of joint production of the Russian vaccine against coronavirus Sputnik V. The batch of the drug for laboratory research will arrive in the country by the end of this week.
Russia's Minister Industry and Trade Denis Manturov held talks with the Prime Minister of Serbia Ana Brnabic.
The Russian participants informed the Serbian side of the progress of work on the mass production of the Sputnik V vaccine in Russia. According to Ana Brnabic, Serbia is ready to explore the possibility of joint production of this drug, RIA Novosti quotes the statement of the Ministry of Industry and Trade.
Denis Manturov said Serbia would receive a 20-dose batch of vaccines for laboratory research by the end of this week.
NEWS.ru reported earlier that Russia's Gamaleya Center, the developer of the first Russian vaccine against coronavirus infection Sputnik V, had proposed combining it with the AstraZeneca vaccine to increase its effectiveness.
'The AstraZeneca vaccine is currently 62 percent effective. If they conduct new clinical trials, we propose to combine the AstraZeneca vaccine with Sputnik V to increase the effectiveness,' the Gamaleya Center tweeted.
The first Russian vaccine against coronavirus infection Sputnik V was registered on August 11 after successful clinical trials. A post-registration trial of the drug is underway on 40,000 volunteers.